本页面由Tiger Trade Technology Pte. Ltd.提供服务

Royalty Pharma plc

61.31
+0.73001.21%
盘前60.96-0.3500-0.57%07:11 EDT
成交量:232.51万
成交额:1.42亿
市值:353.72亿
市盈率:32.89
高:61.60
开:60.53
低:60.37
收:60.58
52周最高:62.13
52周最低:34.08
股本:5.77亿
流通股本:3.93亿
量比:0.94
换手率:0.59%
股息:0.91
股息率:1.48%
每股收益(TTM):1.86
每股收益(LYR):1.78
净资产收益率:13.97%
总资产收益率:5.09%
市净率:5.18
市盈率(LYR):34.42

数据加载中...

2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/04

重要事件披露

Form 8-K - Current report
2026/05/28

重要事件披露

Form 8-K - Current report
2026/05/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report